Management of Asymptomatic Hypoglycemia in Infants of Diabetic Mothers

Initial Assessment and Risk Stratification

The American Academy of Pediatrics recommends that infants of diabetic mothers (IDM) be screened for hypoglycemia, as they are at high risk, with a prevalence of neonatal hypoglycemia ranging from 10-40% 3
Infants with a birth weight of 2580 grams, likely small for gestational age (SGA), are at increased risk of hypoglycemia due to limited glycogen stores 1
The age of 9 hours is within the critical 24-48 hour window when maternal hyperglycemia-induced fetal hyperinsulinism persists while maternal glucose supply has ceased 3

The American College of Clinical Endocrinologists recommends using a blood gas analyzer with glucose module rather than handheld glucometers for accurate measurement in neonates 1

The American Academy of Pediatrics recommends initiating breast-feeding or formula feeding immediately, and if blood glucose remains below 2.5 mmol/L (45 mg/dL) after feeding, starting intravenous dextrose therapy with D10% isotonic solution at 4-8 mg/kg/min 1
The target is to maintain blood glucose ≥2.5 mmol/L (45 mg/dL) consistently, with blood glucose measurement every 30-60 minutes initially 1

The mechanism of hyperinsulinemic hypoglycemia in IDM infants involves maternal hyperglycemia during pregnancy inducing fetal pancreatic beta-cell hyperplasia, resulting in fetal hyperinsulinism that persists 24-48 hours postpartum 3
This hyperinsulinemic hypoglycemia carries the highest risk for brain injury among all causes of neonatal hypoglycemia, with severe and prolonged hypoglycemia associated with neurologic injury including impaired visual-motor processing, executive functioning deficits, and reductions in literacy and numeracy skills in mid-childhood 1